Stock Comparison

SAVA vs UNH

SAVA vs UnitedHealth Group Inc

The Verdict

SAVA takes this one.

Winner

SAVA

1.5

out of 10

Distressed

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

N/A

Market Cap

$276.2B

N/A

P/E Ratio

22.9

N/A

Profit Margin

2.7%

N/A

Return on Equity

12.5%

N/A

Debt-to-Equity

0.0

Aggressive

Overall Risk

Moderate-High

1.5

DVR Score

0.3

The Deep Dive

SAVA1.5/10

Cassava Sciences continues to face an existential crisis due to unresolved allegations of data manipulation and ongoing regulatory investigations by the FDA and NIH concerning its lead drug candidate, simufilam. While the Alzheimer's market offers theoretical 10x growth potential, this is fundamentally undermined by a profound trust deficit in leadership and the scientific integrity of their core ...

Full SAVA Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.